ABSTRACT NUMBER: ESOC2026A2404 CLINICAL AND FUNCTIONAL IMPACT OF THERAPEUTIC DIRECT ORAL ANTICOAGULANT LEVELS IN BREAKTHROUGH ISCHEMIC STROKE
Federica Rizzo, Giulio Fiore, Claudia Meza, Marta Olive, Marián Muchada, Juega Jesús, Marta Rubiera, Carlos A Molina, Jorge Pagola · 2026
Read ABSTRACT NUMBER: ESOC2026A2404 CLINICAL AND FUNCTIONAL IMPACT OF THERAPEUTIC DIRECT ORAL ANTICOAGULANT LEVELS IN BREAKTHROUGH ISCHEMIC STROKE by Federica Rizzo, Giulio Fiore, Claudia Meza, Marta Olive, Marián Muchada, Juega Jesús, Marta Rubiera, Carlos A Molina, Jorge Pagola (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146824.txt.
Description
Federica Rizzo and co-authors test whether blood-thin drug levels at stroke start shape fate when strokes break through care. The study appeared in 2026. Strokes can hit past such drugs, and what the drug's blood level means then was not clear. Near one hundred stroke-code cases with levels at the door fed the read.
Big blocks, first stroke grade, and rush cures sat near flat by level group. Yet folks with full drug levels won free life at three months far less oft than those with low levels, near eighteen in a hundred next to forty-two. The full-level group bore more past frailty and side ills, which may drive the gap.
Catalog record
| CREATOR | Federica Rizzo, Giulio Fiore, Claudia Meza, Marta Olive, Marián Muchada, Juega Jesús, Marta Rubiera, Carlos A Molina, Jorge Pagola |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |